123 related articles for article (PubMed ID: 16732464)
21. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine fights major depressive disorder.
Wimett L; Laustsen G
Nurse Pract; 2005 Mar; 30(3):6-7. PubMed ID: 15753808
[No Abstract] [Full Text] [Related]
23. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
Wohlreich MM; Watkin JG; Gonzales JS
J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
[No Abstract] [Full Text] [Related]
24. Management of depression in the presence of pain symptoms.
Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
[TBL] [Abstract][Full Text] [Related]
26. Individual residual symptoms and functional impairment in patients with depression.
Romera I; Pérez V; Quail D; Berggren L; Lenox-Smith A; Gilaberte I
Psychiatry Res; 2014 Dec; 220(1-2):258-62. PubMed ID: 25149132
[TBL] [Abstract][Full Text] [Related]
27. Physical symptoms of depression: unmet needs in special populations.
Stewart DE
J Clin Psychiatry; 2003; 64 Suppl 7():12-6. PubMed ID: 12755647
[TBL] [Abstract][Full Text] [Related]
28. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
29. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
Gupta S; Nihalani N; Masand P
Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
[TBL] [Abstract][Full Text] [Related]
30. [Effective treatment of depression. Early reduction of painful concomitant symptoms increases the probability of remission].
Ameri AA
MMW Fortschr Med; 2010 Nov; 152(44):78-9. PubMed ID: 21158181
[No Abstract] [Full Text] [Related]
31. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine treatment of Premenstrual Dysphoric Disorder: case reports.
Ramos MG; Hara C; Rocha FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):579-80. PubMed ID: 17897763
[No Abstract] [Full Text] [Related]
33. New hope in the treatment of painful symptoms in depression.
Briley M
Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: a case report.
Chao JY; Shai HA
Gen Hosp Psychiatry; 2010; 32(6):647.e5-6. PubMed ID: 21112463
[TBL] [Abstract][Full Text] [Related]
35. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
[TBL] [Abstract][Full Text] [Related]
36. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
37. Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
Schneider E; Linden M; Weigmann H; Wagner T; Quail D; Hundemer HP; Hegerl U
BMC Psychiatry; 2011 Sep; 11():150. PubMed ID: 21933428
[TBL] [Abstract][Full Text] [Related]
38. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
39. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
40. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.
Strawn JR; Whitsel R; Nandagopal JJ; Delbello MP
J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):91-2. PubMed ID: 21309700
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]